| Date Initiated by Firm | December 15, 2005 |
| Date Posted | January 06, 2006 |
| Recall Status1 |
Terminated 3 on August 07, 2007 |
| Recall Number | Z-0327-06 |
| Recall Event ID |
34238 |
| |
| Product Classification |
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) - Product Code LOM
|
| Product | Vitros Immunodiagnostic HBsAg CONFIRMATORY KIT * REF 680 1324. Firm on label: Ortho-Clinical Diagnostics, 62 The Broadway, Amersham, Bucks, UK. UPC *+H221680132412* . Each kit contains: 1 x kit of reagents, and protocol card for HBsAg Confirmatory Kit. According to the firm (but not on label), there are 60 neutralization reactions per confirmatory kit. |
| Code Information |
Lot 5140, exp. 4/13/2006; Lot 5150, exp. 5/31/2006; and Lot 5160, exp. 7/3/2006 |
| FEI Number |
1000136573
|
Recalling Firm/ Manufacturer |
Ortho-Clinical Diagnostics 100 Indigo Creek Dr Rochester NY 14626-5101
|
| For Additional Information Contact | Judy M. Strzepek 908-218-8524 |
Manufacturer Reason for Recall | Increased background signal of the sample diluent in the affected Confirmatory Kits could cause some results to be classified as 'Not Confirmed'. |
FDA Determined Cause 2 | Other |
| Action | Letters sent overnight mail on 12/15/2005. Customers instructed to discontinue use and discard remaining inventory. In a separate Q&A sheet, Ortho recommends that previously reported results be reviewed. |
| Quantity in Commerce | 436 kits |
| Distribution | Nationwide distribution to end users (medical facilities, testing labs and public health agencies). One J&J foreign affiliate in Puerto Rico with sub-distribution in the Caribbean. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|